Christopher Micallef
Plastic and Reconstructive Surgery · Fort Sam Houston, TXNPI 1154557502
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (53.5%), travel and lodging and education — rather than concentrated in one kind of arrangement. 19 manufacturers reported payments, led by AbbVie at 57.6% of the total. Reporting peaked in 2023 at $4,021 and has fallen 69.6% since, to $1,222 in 2025.
Across 131 payments — averaging $120.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$9K
- TELA Bio, Inc.$2K
- Sientra, Inc.$900
- Zimmer Biomet$788
- Mentor Worldwide LLC$686
- Next Science LLC$482
- plus $2K from 13 others
What the payments were for
- Travel & lodging$7,01745%
- Food & beverage$8,42454%
- Education$3022%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 69 | $9,060 |
| TELA Bio, Inc. | 11 | $1,792 |
| Sientra, Inc. | 3 | $900 |
| Zimmer Biomet | 11 | $788 |
| Mentor Worldwide LLC | 10 | $686 |
| Next Science LLC | 5 | $482 |
| Bard Peripheral Vascular, Inc. | 2 | $333 |
| Stryker | 1 | $302 |
| Solta Medical, A Division Of Bausch Health US, LLC | 3 | $234 |
| Revance Therapeutics, Inc. | 4 | $205 |
| Davol Inc. | 2 | $198 |
| Organogenesis Inc. | 2 | $182 |
| BD | 1 | $160 |
| Kerecis Limited | 1 | $141 |
| Acell, Inc. | 1 | $124 |
| Merz North America, Inc. | 1 | $84 |
| Galderma Laboratories, L.p. | 2 | $43 |
| Pacira Pharmaceuticals Incorporated | 1 | $18 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NATRELLE SALINE-FILLED BREAST IMPLANTS$10,763
- REVOLVE$4,119
- STRATTICE RECONSTRUCTIVE TISSUE MATRIX BPS$3,934
- OviTex Reinforced Bioscaffold With Permanent Polymer (OviTex)$1,525
- SIENTRA HIGH STRENGTH COHESIVE SILICONE GEL BREAST IMPLANT$900
- CMF & Thoracic Product Portfolio$571
- MENTOR MemoryGel Resterilizable Gel Sizer$459
- BOTOX$451
- Kerecis Omega3 SurgiClose$423
- SurgX$372
- Xperience$372
- BlastX$372
- GalaFLEX$333
- UNIVERSAL MANDIBLE$302
- Phasix Mesh$160
- OviTex 2S$157
- Kerecis Omega3 GraftGuide$141
- Kerecis Omega3 Marigen$141
- Puraply Antimicrobial$108
- Walter$103
How this compares
$15,743 in reported general payments places this provider in the 85th percentile of 378 plastic and reconstructive surgery providers in Texas.
See all plastic and reconstructive surgery providers in Texas →
Other plastic and reconstructive surgery in Fort Sam Houston
- Aldona SpiegelHouston$759K
- Charles ButlerHouston$227K
- Michael KlebucHouston$204K
- Joshua LemmonRichardson$118K
- Patrick GarveyHouston$117K
- Rukmini RednamHouston$113K
- Edward ChangHouston$111K
- Alina SholarAustin$110K
- Ashley SteinbergBellaire$102K
- Eric MinnsLubbock$98K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.